الملخص
Objectives: Hospitalisations related to COVID-19 pneumonia have increased the risk of healthcare-associated infections (HCAIs), including those caused by multidrug-resistant organisms (MDROs). This study aimed to investigate the epidemiology of HCAIs secondary to MDROs among hospitalised patients with COVID-19 pneumonia. Methods: This retrospective study population included patients with COVID-19 pneumonia aged 18 years and older who were admitted to Sultan Qaboos University Hospital, Muscat, Oman, for more than 48 hours between March 2020 and December 2021. Results: A total of 486 patients were included in this study. Among the cohort, 76 patients (15.6%) were diagnosed with concurrent HCAIs with an MDRO as the causative pathogen. Of these patients, 31 (40.8%) had infections caused by MDR Acinetobacter baumannii, 15 (19.7%) had infections secondary to carbapenem-resistant Klebsiella pneumoniae and 8 (10.5%) had infections caused by extended-spectrum betalactamase Escherichia coli. Pneumonia and bacteraemia were the two most common concurrent healthcare-associated MDRO infection sites, accounting for 42% and 36% of all events, respectively. Among the 486 patients, 155 died (31.9%). Among these, 64 (41.3%) had concurrent HCAIs caused by 1 or more MDROs. Contrarily, among the 331 patients with COVID-19 pneumonia who recovered, only 12 (3.6%) had concurrent HCAIs. Conclusions: There is high prevalence of healthcare-associated MDRO infections.predominantly pneumonia and bacteraemia.in hospitalised patients with COVID-19 pneumonia. This reveals a significant association between infection with MDROs and death underlining the substantial impact of infection with MDROs in this vulnerable patient population.
بيانات النشر
- المعرّف الرقمي
- 10.18295/2075-0528.2826
- المجلة
- مجلة جامعة السلطان قابوس الطبية, 25(1), 186-190
- الناشر
- جامعة السلطان قابوس
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-ND 4.0
اقتبس هذه المقالة
APA 7
Al Hanashi, Y., & Balkhair, A. (2025). Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience. Sultan Qaboos University Medical Journal, 25(1), 186-190. https://doi.org/10.18295/2075-0528.2826
MLA 9
Al Hanashi, Yahyia, and Abdullah Balkhair. "Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience." Sultan Qaboos University Medical Journal, vol. 25, no. 1, 2025, pp. 186-190. https://doi.org/10.18295/2075-0528.2826.
شيكاغو (المؤلف–التاريخ)
Al Hanashi, Yahyia, and Abdullah Balkhair. 2025. "Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience." Sultan Qaboos University Medical Journal 25 (1): 186-190. https://doi.org/10.18295/2075-0528.2826.
هارفارد
Al Hanashi, Y. and Balkhair, A. (2025) 'Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience', Sultan Qaboos University Medical Journal, 25(1), pp. 186-190. doi:10.18295/2075-0528.2826.
فانكوفر
Al Hanashi Y, Balkhair A. Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience. Sultan Qaboos University Medical Journal. 2025;25(1):186-190. doi:10.18295/2075-0528.2826
IEEE
Y. Al Hanashi, and A. Balkhair, "Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: A single-centre experience," Sultan Qaboos University Medical Journal, vol. 25, no. 1, pp. 186-190, 2025, doi: 10.18295/2075-0528.2826.